MedTrace Logo

Integrative Group Program for Type 2 Diabetes Mellitus (T2DM)

NCT05888454 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-02-29

No results posted yet for this study

Summary

This is an open, randomized, controlled trial to determine the impact of an integrative group program on metabolic control and wellbeing perception of patients with T2DM. The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions during a period of 12 weeks.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Integrative Group Program

The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions during a period of 12 weeks.

OTHER

Conventional treatment for T2DM

Conventional medical treatment for T2DM

Sponsors & Collaborators

  • TecSalud

    collaborator UNKNOWN

  • Fundación Santos y de la Garza Evia I.B.P

    collaborator UNKNOWN

  • TecSalud Investigación Clínica

    lead OTHER

Principal Investigators

  • Tania Zertuche, MD · Director de Instituto de Bienestar y Prevención

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888454 on ClinicalTrials.gov